Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drug rebound headaches].

A Prusiński1

  • 1Katedry i Kliniki Neurologii AM w Lodzi.

Neurologia I Neurochirurgia Polska
|December 7, 2000
PubMed
Summary

Drug rebound headaches, often daily for migraine and tension headache sufferers, stem from continuous analgesic use. Complete drug cessation, aided by antidepressants like opipramol, offers effective relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tolerability and efficacy of almotriptan in the long-term treatment of migraine.

European neurology·2001
Same author

[Selected problems for discussion of procedures in epilepsy].

Neurologia i neurochirurgia polska·2000
Same author

[Emergency treatment of migraine attacks with particular reference to agonists of 5-HT1B/1D receptor].

Neurologia i neurochirurgia polska·2000
Same author

[Insomnia and its treatment].

Neurologia i neurochirurgia polska·2000
Same author

Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study.

Cephalalgia : an international journal of headache·2000
Same author

[Feverfew as a prophylactic treatment of migraine].

Neurologia i neurochirurgia polska·2000

Area of Science:

  • Neurology
  • Pharmacology

Context:

  • Drug rebound headache, a consequence of daily analgesic or ergotamine use, affects an estimated 20% of chronic headache patients.
  • Characterized by a vicious cycle mechanism, these headaches necessitate a specific treatment approach.

Purpose:

  • To investigate the efficacy of immediate and complete drug withdrawal for managing drug rebound headaches.
  • To evaluate the use of opipramol as an adjunctive treatment during the withdrawal phase.

Summary:

  • The study observed 47 patients (45 women, mean age 41) experiencing drug rebound headaches for an average of 3 years.
  • A treatment protocol involving gradual opipramol administration followed by complete analgesic cessation was implemented.
  • Good results were achieved in 32 patients, with 10 unable to fully discontinue analgesics.

Impact:

  • Immediate drug cessation, supported by antidepressants, can disrupt the cycle of drug rebound headaches.
  • This approach offers a viable treatment strategy for a significant subset of chronic headache sufferers.
  • Highlights the importance of identifying and addressing medication overuse in headache management.

Related Experiment Videos